Eli Lilly and Company (NYSE ... Biden's recent decision to expand Medicare and Medicaid coverage could usher in a new ...
Novo Nordisk A/S has fallen behind Eli Lilly & Co. this year in the race to be the big stock market winner from obesity drugs. Analysts expect the Danish company to start catching up. Less ...
A new investigation found that such medicines can reduce the risk of Alzheimer's. While this new opportunity will take some time to cook before it's ready to delight shareholders, one of the two ...
Novo Nordisk faces challenges in weight-loss sector, but acquisition and strong diabetes portfolio position it for future ...
As I write this, the stock has fallen by 12% just in ... As far as competition goes, Eli Lilly is one of the two ...
Today, Mounjaro and Zepbound both have become blockbusters, and in the most recent quarter, they generated $3.1 billion and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback